Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Regado Biosciences' REG2 investigational new drug application accepted by FDA
Yahoo/Fly on the Wall
Thursday, February 13, 2014 - 9:14am
tags:
Regado Biosciences, REG2, subacute venous thrombosis
Now That Statins Are Cheap, More UK Patients Can Take Them
Forbes
Thursday, February 13, 2014 - 9:13am
tags:
UK, statins
Chelsea Therapeutics: The Good, The Bad And The Ugly
Seeking Alpha
Thursday, February 13, 2014 - 9:12am
tags:
Chelsea Therapeutics, FDA, Northera
Boehringer facing more than 2,000 U.S. lawsuits over blood thinner
Yahoo/Reuters
Thursday, February 13, 2014 - 9:11am
tags:
bloodthinners, Pradaxa, Boehringer Ingelheim
FDA Advisory Panel Recommends Against Approval Of New Medicines Company Heart Drug
Forbes
Wednesday, February 12, 2014 - 6:52pm
tags:
FDA, advisory panels, The Medicines Company, Cangrelor
Senators question FDA over hydrocodone painkiller
Yahoo/AP
Wednesday, February 12, 2014 - 6:50pm
tags:
FDA, Senate, hydrocodone, Zohydro, Zogenix
Merck consumer-brand portfolio could fetch $10B, WSJ says
The Fly on the Wall
Wednesday, February 12, 2014 - 6:49pm
tags:
Merck, consumer health
Here's Why Biogen Could Be in Store for a Big 2014
Motley Fool
Wednesday, February 12, 2014 - 6:48pm
tags:
Biogen Idec, Tecfidera, Eloctate, Alprolix, daclizumab, Gazyva
J&J, Pharmacyclics drug gets U.S. approval for leukemia
Yahoo/Reuters
Wednesday, February 12, 2014 - 6:46pm
tags:
FDA, JNJ, Pharmacyclics, Imbruvica, chronic lymphocytic leukemia
Sanofi under pressure to divulge plans for its cash stash
Fierce Pharma
Wednesday, February 12, 2014 - 12:38pm
tags:
Sanofi
What's Holding up FDA's Electronic Drug Labeling Rule?
Regulatory Focus
Wednesday, February 12, 2014 - 12:02pm
tags:
FDA, electronic labeling
Biotechs pocket another $115M as the IPO boom thunders on
Fierce Biotech
Wednesday, February 12, 2014 - 11:59am
tags:
biotech, IPOs, Flexion, Eagle Pharmaceuticals
Galena Biopharma Pays For Stock-Touting Campaign While Insiders Cash Out Millions
TheStreet.com
Wednesday, February 12, 2014 - 10:13am
tags:
Galena Biopharma
Dara BioSciences raises $6M in a registered direct offering
Yahoo/Fly on the Wall
Wednesday, February 12, 2014 - 10:10am
tags:
DARA Biosciences, stock offering
StemCells finishes enrolling first of two patient cohorts in HuCNS-SC study
Yahoo/Fly on the Wall
Wednesday, February 12, 2014 - 10:09am
tags:
StemCells, clinical trials, HuCNS-SC, dry age-related macular degeneration
Amgen Inc's Deep Pipeline Offsets Some of the Price Risk
Motley Fool
Wednesday, February 12, 2014 - 10:07am
tags:
Amgen, earnings, evolocumab
Reckitt Benckiser says pharma review ongoing
Yahoo/Reuters
Wednesday, February 12, 2014 - 10:05am
tags:
Reckitt Benckiser
Actelion’s Lung Drug May Face Study Against Gilead Rival
Bloomberg
Wednesday, February 12, 2014 - 9:50am
tags:
Actelion, Gilead Sciences, Opsumit, Letairis, PAH, pulmonary arterial hypertension
Prediction: Chelsea Wins Northera FDA Approval Friday
TheStreet.com
Wednesday, February 12, 2014 - 9:48am
tags:
Chelsea Therapeutics, Northera, FDA
3 Ways Ariad Pharmaceuticals Can Salvage Iclusig
Motley Fool
Wednesday, February 12, 2014 - 9:19am
tags:
Ariad Pharmaceuticals, Iclusig, acute lymphoblastic leukemia

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.